Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Indian J Pharmacol ; 47(3): 280-4, 2015.
Article in English | MEDLINE | ID: mdl-26069365

ABSTRACT

OBJECTIVE: Charybdotoxin-C (ChTx-C), from the scorpion Leiurus, quinquestriatus hebraeus blocks the calcium-activated potassium channels and causes hyper excitability of the nervous system. Detailed understanding the structure of ChTx-C, conformational stability, and intermolecular interactions are required to select the potential inhibitors of the toxin. MATERIALS AND METHODS: The structure of ChTx-C was modeled using Modeller 9v7. The amino acid residues lining the binding site were predicted and used for toxin-ligand docking studies, further, selected toxin-inhibitor complexes were studied using molecular dynamics (MD) simulations. RESULTS: The predicted structure has 91.7% of amino acids in the core and allowed regions of Ramachandran plot. A total of 133 analog compounds of existing drugs for scorpion bites were used for docking. As a result of docking, a list of compounds was shown good inhibiting properties with target protein. By analyzing the interactions, Ser 15, Lys 32 had significant interactions with selected ligand molecules and Val5, which may have hydrophobic interaction with the cyclic group of the ligand. MD simulation studies revealed that the conformation and intermolecular interactions of all selected toxin-inhibitor complexes were stable. CONCLUSION: The interactions of the ligand and active site amino acids were found out for the best-docked poses in turn helpful in designing potential antitoxins which may further be exploited in toxin based therapies.


Subject(s)
Antitoxins/chemistry , Antitoxins/pharmacology , Charybdotoxin/antagonists & inhibitors , Charybdotoxin/chemistry , Drug Design , Molecular Docking Simulation , Molecular Dynamics Simulation , Potassium Channel Blockers/antagonists & inhibitors , Animals , Catalytic Domain , Computer Simulation , Ligands , Potassium Channel Blockers/chemistry , Protein Conformation , Scorpions/chemistry
2.
Life Sci ; 66(12): 1097-104, 2000 Feb 11.
Article in English | MEDLINE | ID: mdl-10737360

ABSTRACT

We reported previously that acetylcholine (ACh)-induced endothelium-dependent relaxation of rat mesenteric microvessels depended both on nitric oxide (NO) and on a charybdotoxin (CTX)-sensitive endothelium-derived hyperpolarizing vasodilator. Cytochrome P450 (CYP)-dependent arachidonic acid metabolites act in some systems as hyperpolarizing vasodilators. We sought to quantitate contributions of such metabolites to the CTX-sensitive component of ACh-induced vasodilation in isolated rat mesenteric resistance arteries. ACh relaxed these vessels nearly completely (93.3+/-1.2%, n = 71); cyclooxygenase inhibition with indomethacin did not diminish this response (94.3+/-11.4%, n = 9). NO synthase inhibition with Nitro-L-arginine (NNLA) reduced relaxation by 30% (n = 54, p<0.05). Pretreatment of vessels with CYP inhibitors, either clotrimazole (CTM) or 17-octadecynoic acid (17-ODYA), or with selective K+ channel inhibitors, either tetraethyammonium acetate (TEA) or CTX, each led to similar small reductions in maximal relaxation (17%, 22%, 16%, and 9% respectively, n = 3-6). Combined pretreatment with NNLA + either (CTM or 17-ODYA) or (TEA or CTX) each led to similar maximal relaxations (52.2+/-4.8%, 50.6+/-9.2, 37.6+/-8.6%, and 44.1+/-11.5%, respectively, n = 6-35; p<0.05 for NNLA+[CTM or TEA or CTX] vs NNLA alone). Combined pretreatment with NNLA+CTM+(CTX or TEA) led to similar maximal relaxations (43.0+/-7.3%, 43.7+/-15%, n = 6-11) that did not differ from values in vessels pretreated with either NNLA+CTM or NNLA+(CTX or TEA). We conclude that the ACh-induced vasodilation was insensitive to cyclooxygenase inhibition, partially sensitive to NO synthase inhibition, and that the K+ channel blockers TEA and CTX identified the same minor component of ACh relaxation as did the CYP inhibitor CTM.


Subject(s)
Cytochrome P-450 Enzyme System/physiology , Endothelium, Vascular/physiology , Mesenteric Arteries/physiology , Vasodilation/physiology , Acetylcholine/pharmacology , Animals , Arginine Vasopressin/pharmacology , Charybdotoxin/antagonists & inhibitors , Charybdotoxin/pharmacology , Cytochrome P-450 Enzyme Inhibitors , Dose-Response Relationship, Drug , Drug Combinations , Enzyme Inhibitors/pharmacology , Male , Nitric Oxide/physiology , Nitric Oxide Synthase/antagonists & inhibitors , Potassium Channels/drug effects , Rats , Rats, Sprague-Dawley , Vasodilation/drug effects
3.
Life Sci ; 63(12): 1047-55, 1998.
Article in English | MEDLINE | ID: mdl-9749827

ABSTRACT

Nitroglycerin (NTG), a nitric oxide (NO) donor, is considered to relax vascular smooth muscle by stimulating soluble guanylate cyclase, which in turn increases cyclic GMP (cGMP) level. Recently it became evident that NO-induced vasodilatation is also mediated by stimulating Ca-activated K (K(Ca)) channels directly and/or indirectly through cGMP. We, therefore, tried to investigate the possible involvement or the alteration of K(Ca) channels in the mechanism of vasodilation induced by NTG in physiological and pathological conditions. Using rings prepared from thoracic aortas of spontaneously hypertensive rats (SHR) and those of age-matched Wistar-Kyoto rats (WKY), we studied changes in isometric tension of the rings in response to NTG to evaluate effects of a soluble guanylate cyclase inhibitor methylene blue (MB), and a specific blocker of K(Ca) channel charybdotoxin (CTX). Rings from WKY and SHR precontracted with norepinephrine showed similar aortic relaxation to NTG. MB markedly suppressed the NTG-induced relaxation in both strains, leaving about 30% of MB-resistant relaxation. CTX nearly completely eliminated this MB-resistant relaxation in WHY but did not affect this relaxation in SHR. These results suggest that NTG-induced vasorelaxation is mediated through i) cGMP-dependent and ii) cGM P-independent K(Ca) channel involving mechanisms, the latter may be diminished or virtually eliminated in hypertensive state.


Subject(s)
Aorta, Thoracic/drug effects , Calcium/physiology , Hypertension/metabolism , Muscle, Smooth, Vascular/drug effects , Nitroglycerin/pharmacology , Potassium Channels/metabolism , Vasodilator Agents/pharmacology , Animals , Blood Pressure/drug effects , Charybdotoxin/antagonists & inhibitors , Charybdotoxin/pharmacology , Guanylate Cyclase/antagonists & inhibitors , Guanylate Cyclase/metabolism , Hypertension/genetics , In Vitro Techniques , Male , Methylene Blue/pharmacology , Muscle Contraction/drug effects , Muscle Relaxation/drug effects , Norepinephrine/antagonists & inhibitors , Norepinephrine/pharmacology , Potassium Channels/drug effects , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Vasoconstrictor Agents/antagonists & inhibitors , Vasoconstrictor Agents/pharmacology
4.
Fundam Clin Pharmacol ; 11(1): 78-82, 1997.
Article in English | MEDLINE | ID: mdl-9182080

ABSTRACT

The smooth muscle relaxant responses to NS-004, an activator of charybdotoxin-sensitive, large conductance Ca(2+)-dependent K+ channels (BKCa) were studied on the basal spontaneous tone in guinea-pig trachea in vitro. The sensitivity of these responses to a range of K+ channel inhibitors and antagonists were also evaluated. NS-004 (0.1-30 microM) evoked concentration-related relaxations (pIC50 5.48 +/- 0.13) on the spontaneous tone in guinea-pig tracheal rings, suspended in Krebs bicarbonate solution, with a maximum response not different to that to aminophylline (1 microM). Charybdotoxin (0.03 and 0.1 microM) or iberiotoxin (0.1 microM) significantly displaced the NS-004 concentration-response curve to the right of control with no change in maximum response. In contrast, glibenclamide (1.0 microM) apamin (0.1 microM) and dofetilide (1.0 microM) each failed to modify the responses to NS-004 on spontaneous tone in guinea-pig trachea. These results suggest that relaxations in guinea-pig tracheal smooth muscle to the substituted benzimidazolone, NS-004, involve the activation of BKCa channels.


Subject(s)
Benzimidazoles/pharmacology , Chlorophenols/pharmacology , Muscle Relaxation/drug effects , Potassium Channel Blockers , Trachea/drug effects , Animals , Anti-Arrhythmia Agents/pharmacology , Apamin/pharmacology , Charybdotoxin/antagonists & inhibitors , Dose-Response Relationship, Drug , Glyburide/pharmacology , Guinea Pigs , Hypoglycemic Agents/pharmacology , Linear Models , Male , Muscle Relaxation/physiology , Muscle, Smooth/drug effects , Peptides/antagonists & inhibitors , Phenethylamines/pharmacology , Sulfonamides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...